Published online before print February 12, 2009, doi: 10.1161/CIRCGENETICS.108.825273
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Articles |
Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women
The Women’s Genome Health Study
From the Center for Cardiovascular Disease Prevention (J.S.D., G.P., D.I.C., R.Y.L.Z., P.M.R.), Donald W. Reynolds Center for Cardiovascular Research (J.S.D., D.I.C., R.Y.L.Z., D.J.K., P.M.R.), and Translational Medicine Division, Brigham and Women’s Hospital (D.J.K.), Boston, Mass; and Amgen, Inc (A.P., J.P.M.), Cambridge, Mass.
Correspondence to Jacqueline Suk Danik, MD, MPH, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215. E-mail jdanik{at}partners.org
Received September 30, 2008; accepted December 9, 2008.
Background— Fibrinogen is a multifunctional circulating glycoprotein involved in wound healing, thrombosis, platelet aggregation, and inflammation, and elevated levels predict vascular disease. Despite evidence of crucial biological function and moderate heritability, comprehensive analysis of the influence of genetic variation on fibrinogen is not available.
Methods and Results— To address this issue, we undertook a genome-wide association study evaluating the potential relationships between 337 343 single-nucleotide polymorphisms (SNPs) and plasma fibrinogen levels among 17 686 apparently healthy women participating in the Women’s Genome Health Study. As C-reactive protein is also an inflammatory marker known to predict cardiovascular diseases, we compared the determinants of fibrinogen levels with those of C-reactive protein. Four novel loci were identified, in addition to the fibrinogen gene cluster, which were associated with fibrinogen levels at genome-wide levels of significance (range of probability values from 8.82x10–09 to 8.04x10–39). Two of the loci are related to common chronic inflammatory diseases: the first, at locus 5q31.1 (SLC22A5, SLC22A4, IRF1), lies immediately adjacent to a locus linked to Crohn disease (P value for lead SNP, 1.24x10–12) and the second, at locus 17q25.1 (CD300LF, SLC9A3R1, NAT9), has been associated with psoriasis (P value for lead SNP, 7.72x10–11). A third locus at 1q21.3 (IL6R) lies within the interleukin 6 receptor gene, a critical component of the inflammatory cascade (P value for lead SNP, 1.80x10–11). A novel locus at 2q34 (CPSI) participates in the urea cycle (P=8.82x10–09). The majority of implicated SNPs showed little evidence of dual association with C-reactive protein levels.
Conclusions— A genome-wide survey of the human genome identifies novel loci related to common chronic inflammatory diseases as genetic determinants of fibrinogen levels, in addition to loci that relate to the inflammatory cascade, the urea cycle, and the fibrinogen gene cluster.
Key Words: fibrinogen • genetics • inflammation • coagulation • women
CLINICAL PERSPECTIVE
*Drs Danik and Pare contributed equally to this work.Guest Editor for this article was Donna K. Arnett, PhD.
Related Article
Circ Cardiovasc Genet 2009 2: 134-141.